InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Pops Richard F, Chief Executive Officer. Insider active across 2 companies, notably Alkermes plc.. In total, 18 disclosures have been logged. History available since 6 May 2021. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pops Richard F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
149,580 sharesOrdinary SharesSEC:0001520262-26-000019:0
2,869 shares0Common StockSEC:0000914475-25-000129:0
190,640 sharesOrdinary SharesSEC:0001127602-25-003685:0
4,199 shares0Common StockSEC:0000914475-24-000136:0
23,200 shares@ US$42.7665.7% of flowCommon StockSEC:0000914475-24-000092:0
1,700 shares@ US$42.764.8% of flowCommon StockSEC:0000914475-24-000088:0
15,000 shares@ US$12.9813.1% of flowCommon StockSEC:0000914475-24-000078:0
218,551 sharesOrdinary SharesSEC:0001127602-24-004634:0
119,713 sharesOrdinary SharesSEC:0001127602-23-006518:0
15,000 shares@ US$12.7112.9% of flowCommon StockSEC:0001209191-23-002053:0
7,500 shares@ US$6.660.0003% mcap100.0% of flowCommon StockSEC:0001209191-22-028369:0
329,153 shares@ US$16.550.11% mcap30.3% of flowOrdinary SharesSEC:0001127602-22-013707:0
32,400 sharesOrdinary SharesSEC:0001127602-22-006324:0
18,125 sharesOrdinary SharesSEC:0001127602-22-005452:0
81,682 shares0Ordinary SharesSEC:0001127602-21-025409:0
150,000 shares@ US$18.10520.0% of flowOrdinary SharesSEC:0001127602-21-017397:0
150,000 shares@ US$18.10520.1% of flowOrdinary SharesSEC:0001127602-21-016394:0
100,000 shares@ US$18.10513.5% of flowOrdinary SharesSEC:0001127602-21-015894:0
18 of 18 declarations
About Pops Richard F
POPS RICHARD F is Directeur Général. He has 18 filings in total, and across the 18 recent sampled filings, the most frequent transaction nature is option exercise. The sampled filings cover the period from 2021-05-07 to 2026-02-06, with buy amounts of EUR 0 and sell amounts of EUR 0. He is listed at Alkermes plc. as Director and CEO, Alkermes plc, and at Neurocrine Biosciences INC as Director.
